Bioterrorism vaccine development

Since the terrorist attack on New York s World Trade Center, discussions about the global exchange of disease have often focused on bioterrorism. In response to a possible bioterrorist release of smallpox, the U.S. government has stockpiled vaccine and implemented a largely unsuccessful program to vaccinate first responders (Gursky and Parikh 2005). Yet, if smallpox reappears, it will likely do so from the laboratories in the world s most scientifically developed nations. When it comes to infectious diseases, each part of the world threatens and is a threat to its neighbors. 

Developing products to address urgent public health needs, including new antibiotics, vaccines, and medical countermeasures against emerging infections and bioterrorism attacks (see Grey and Spaeth, 2006, Roy, 2004). 

---